key: cord-1053748-2jl11juy
authors: Moro, Elena; Taba, Pille
title: COVID‐19: An unforgettable challenge for the neurology community
date: 2021-06-14
journal: Eur J Neurol
DOI: 10.1111/ene.14937
sha: 9225cd4fb2f135393efbf65c11fc91d65fb6cde9
doc_id: 1053748
cord_uid: 2jl11juy

Without any doubt, the COVID-19 pandemic has marked the world history forever1 . Nowhere and no one has been spared from direct and/or indirect consequences of this unprecedent infectious disease. Sadly, after so many months since its first appearance, SARS-CoV-2 is still thriving and killing people in several countries. The massive national vaccination campaigns are rather slow in most countries and still touching only the tip of the iceberg. We are wondering whether the virus will ever go away and how to manage the years to come.

whether the virus will ever go away and how to manage the years to come.

As neurologists, among the many lessons learned during this pandemic, we have become familiar with the neurological manifestations of COVID-19 infection. At the very beginning of the pandemic, our Chinese colleagues reported that patients with COVID-19 could have several central and peripheral neurological symptoms and signs, and that these neurological findings often occurred in the most severe cases [2] . Since then, together with a better understanding gained of COVID-19 neuropathophysiological mechanisms [3] , an increasing number and type of neurological manifestations in patients with COVID-19 (neuro-COVID-19) have been reported [4] . Several countries have started national registries to retrospectively and prospectively record and follow these patients. The European Academy of Neurology (EAN) has also started a special COVID-19 Task Force and a global registry (ENERGY) to collect the data of patients with neuro-COVID-19 [5] . A massive global effort has also been made by several neurological societies and associations to better understand and treat the neurological consequences of the virus [6, 7] .

In the face of all these developments, the European Journal of Neurology Editorial Board has decided to dedicate a special supplement to highlight the multifaceted impact of COVID-19 on the neurological community.

In this supplement, several aspects of the pandemic con- Nevertheless, the neurology community has learned that neurological manifestations from COVID-19 are not rare, that patients with some chronic neurological diseases may have more severe infection and consequences, and that global efforts are needed to cope with and win the fight against this new infectious disease.

Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: A longitudinal analysis of 200,000 Western and Northern Europeans

Neurologic manifestations of hospitalized patients with coronavirus disease

Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection

The EAN core COVID-19 task force the international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection

The EAN Neuro-COVID Task Force. The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19

COVID-19 Neuro Research Coalition. Approaches to understanding COVID-19 and its neurological associations

Global incidence of neurological manifestations among patients hospitalized with COVID-19-A report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium